Calvin Sternick

Stock Analyst at JP Morgan

(2.47)
# 2,245
Out of 4,786 analysts
19
Total ratings
38.46%
Success rate
6.36%
Average return

Stocks Rated by Calvin Sternick

U.S. Physical Therapy
Mar 19, 2025
Maintains: Overweight
Price Target: $120$110
Current: $72.36
Upside: +52.02%
Centene
Jul 10, 2024
Maintains: Neutral
Price Target: $85$80
Current: $60.71
Upside: +31.77%
PACS Group
May 6, 2024
Initiates: Overweight
Price Target: $27
Current: $11.24
Upside: +140.21%
Universal Health Services
Mar 13, 2024
Maintains: Neutral
Price Target: $144$182
Current: $187.90
Upside: -3.14%
Tenet Healthcare
Nov 17, 2023
Maintains: Overweight
Price Target: $91$81
Current: $134.50
Upside: -39.78%
Molina Healthcare
Nov 17, 2023
Maintains: Overweight
Price Target: $367$392
Current: $329.39
Upside: +19.01%